COSMOS Pharmaceutical Corporation (3349.T)

Better than 9843.T's revenue of 1.29T.

Better than 9843.T's revenue growth rate of 6.82%.

Better than 9843.T's depreciation of 41.25B.

Better than 9843.T's receivables of 87.20B.

Better than 9843.T's receivables as percentage of revenue of 6.75%.

Better than 9843.T's inventories of 158.91B.

Better than 9843.T's inventories as percentage of revenue of 12.30%.

Better than 9843.T's weighted average cost of capital (wacc) of 6.70%.

Better than 9843.T's cost of equity of 7.20%.

Better than 9843.T's cost of debt of 3.99%.

Better than 9843.T's beta of 0.68.

Better than 9843.T's diluted shares outstanding of 113.01M.

Better than 9843.T's total debt of 203.02B.

Better than 9843.T's debt weighting of 11.14%.

Better than 9843.T's equity weighting of 88.86%.

Better than 9843.T's long-term growth rate of 1.00%.

Better than 9843.T's net debt of 41.10B.

Better than 9843.T's equity value per share of 3035.93.